Riskpilot← Back to searchSign inGet full accessLace Laboratory AB
ABActiveOrg 5591264220Sturegatan 24 4trManufacture of underwear · NACE 1422Est. 20175-9 employees
Revenue 2024
SEK 18,5M
+10% vs 2023
EBITDA margin
-11.4%
+34% vs 2023
Equity ratio
-150.9%
Financial strength
Net profit 2024
SEK -2,7M
+32% vs 2023
| Revenue | SEK 18,5M | +10% |
| EBITDA | SEK -2,1M | +34% |
| Net profit | SEK -2,7M | +32% |
| Total assets | SEK 6,1M | -22% |
| Equity | SEK -9,2M | -18% |
| Employees | — | — |
Legal name
Lace Laboratory AB
Org number
5591264220
Legal form
Aktiebolag
NACE code
1422 · Manufacture of underwear
Founded
25 september 2017
Share capital
SEK 85 992
Employees
5-9
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas av de Geer, Faye Alexandra Electra i förening med en av ledamöterna
Company purpose
Föremålet för bolagets verksamhet är import och försäljning av kläder, skor, accessoarer, smycken och därmed förenlig verksamhet.
Address
Sturegatan 24 4tr
Email
faye@lacelaboratory.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 15 284 | 18 652 | 15 501 | 16 864 | 18 499 |
| Staff expenses | — | — | −5 994 | −3 153 | −1 736 |
| EBITDA | −4 845 | −15 923 | −7 077 | −3 200 | −2 115 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | −4 845 | −15 923 | −7 077 | −3 200 | −2 115 |
| Net financials | −8 | −204 | −295 | −706 | −554 |
| Profit before tax | −4 853 | −16 127 | −7 373 | −3 906 | −2 669 |
| Tax | −0 | −0 | — | — | — |
| Net profit | −4 853 | −16 127 | −7 373 | −3 906 | −2 669 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 5 956 | 10 434 | 9 641 | 7 831 | 6 082 |
| Equity | 679 | 2 599 | −4 774 | −7 763 | −9 177 |
| Long-term debt | 0 | 1 334 | 8 910 | 9 568 | 1 226 |
| Short-term debt | 5 277 | 6 501 | 5 505 | 6 026 | 14 034 |
| Total debt | 5 277 | 7 835 | 14 415 | 15 594 | 15 259 |
EBITDA margin
-11.4%
This company
15.8%
Market median
-172% vs market
20202024
Equity ratio
-150.9%
This company
38.2%
Market median
-495% vs market
20202024
Return on equity
-266892600.0%
This company
18.4%
Market median
-1450503361% vs market
20202024
Net profit margin
-14.4%
This company
8.1%
Market median
-278% vs market
20202024
Asset turnover
3.04×
This company
1.12×
Market median
+171% vs market
20202024
Debt / equity
1.66×
This company
0.62×
Market median
-168% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
PH Audit | Audit | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
| Chairman | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Lace Laboratory AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Per Hjalmar Lindblom | Audit | 0 companies |
| Joanna Felicia Lönnqvist | Board of Directors | 0 companies |
| Eva Birgitta Flensburg | Deputy Board Member | 0 companies |
| Faye Alexandra Electra de Geer | Chairman | 0 companies |
| Hans Henrik Källén | Board of Directors | 0 companies |